Sox6, A Potential Target for MicroRNAs in Cardiometabolic Disease.
Cardiovascular diseases
Diabetes
Hypertension
Sox6
miRNAs
Journal
Current hypertension reports
ISSN: 1534-3111
Titre abrégé: Curr Hypertens Rep
Pays: United States
ID NLM: 100888982
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
accepted:
18
01
2022
pubmed:
7
2
2022
medline:
1
6
2022
entrez:
6
2
2022
Statut:
ppublish
Résumé
The study aims to review recent advances in knowledge on the interplay between miRNAs and the sex-determining Region Y (SRY)-related high-mobility-group box 6 (Sox6) in physiology and pathophysiology, highlighting an important role in autoimmune and cardiometabolic conditions. The transcription factor Sox6 is an important member of the SoxD family and plays an indispensable role in adult tissue homeostasis, regeneration, and physiology. Abnormal expression of the Sox6 gene has been implicated in several disease conditions including diabetes, cardiomyopathy, autoimmune diseases, and hypertension. Expression of Sox6 is regulated by miRNAs, which are RNAs of about 22 nucleotides, and have also been implicated in several pathophysiological conditions where Sox6 plays a role. Regulation of Sox6 by miRNAs is important in diverse physiological tissues and organs. Dysregulation of the interplay between miRNAs and Sox6 is an important determinant of various disease conditions and may be actionable for therapeutic purposes.
Identifiants
pubmed: 35124768
doi: 10.1007/s11906-022-01175-8
pii: 10.1007/s11906-022-01175-8
doi:
Substances chimiques
MicroRNAs
0
SOX6 protein, human
0
SOXD Transcription Factors
0
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
145-156Subventions
Organisme : FIC NIH HHS
ID : D43 TW009337
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL144941
Pays : United States
Organisme : NHLBI NIH HHS
ID : R03HL155041
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL130497
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.